CoChat

The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates

Open access

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

BACKGROUND: Low muscle mass and weakness are common and potentially disabling in older adults, but in order to become recognized as a clinical condition, criteria for diagnosis should be based on clinically relevant thresholds and independently validated. The Foundation for the National Institutes of Health Biomarkers Consortium Sarcopenia Project used an evidence-based approach to develop these criteria. Initial findings were presented at a conference in May 2012, which generated recommendations that guided additional analyses to determine final recommended criteria. Details of the Project and its findings are presented in four accompanying manuscripts. METHODS: The Foundation for the National Institutes of Health Sarcopenia Project used data from nine sources of community-dwelling older persons: Age, Gene/Environment Susceptibility-Reykjavik Study, Boston Puerto Rican Health Study, a series of six clinical trials, Framingham Heart Study, Health, Aging, and Body Composition, Invecchiare in Chianti, Osteoporotic Fractures in Men Study, Rancho Bernardo Study, and Study of Osteoporotic Fractures. Feedback from conference attendees was obtained via surveys and breakout groups. RESULTS: The pooled sample included 26,625 participants (57% women, mean age in men 75.2 [±6.1 SD] and in women 78.6 [±5.9] years). Conference attendees emphasized the importance of evaluating the influence of body mass on cutpoints. Based on the analyses presented in this series, the final recommended cutpoints for weakness are grip strength <26kg for men and <16kg for women, and for low lean mass, appendicular lean mass adjusted for body mass index <0.789 for men and <0.512 for women. CONCLUSIONS: These evidence-based cutpoints, based on a large and diverse population, may help identify participants for clinical trials and should be evaluated among populations with high rates of functional limitations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/gerona/glu010

Cites

41 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Clinical paradigm.
Figure 1. Clinical paradigm.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

6 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

  • Sarcopenia: revised European consensus on definition and diagnosis

    Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818

    “…kg Dodds (2014) [26] Chair stand >15 s for five rises Cesari (2009) [67] EWGSOP2 sarcopenia cut-off points for low muscle quantity ASM <20 kg <15 kg Studenski (2014) [3] ASM/height2 <7.0 kg/m2 <6.0 kg/m2 Gould (2014) [125] EWGSOP2 sarcopenia cut-off points for low performance Gait speed ≤0.8 m/s…”
    BackgroundInfluential
  • Sarcopenia

    Cruz-Jentoft, A. J., & Sayer, A. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31138-9 · Cited by 3,905

  • GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community

    Cederholm, T., Jensen, G. L., Correia, M. I. T. D., Gonzalez, M. C., Fukushima, R., Higashiguchi, T., Baptista, G., Barazzoni, R., Blaauw, R., Coats, A., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.002 · Cited by 3,022

    “…of recommended cut-off values for muscle mass reductions, GLIM refers to recommendations from the European Working Group on Sarcopenia in Older People (EWGSOP) [15] and from The Foundation of National Institute of Health (FNIH) initiative [16], and the Asian Working Group on Sarcopenia (AWGS) [17].”
    BackgroundMethod
  • ESPEN guideline on clinical nutrition in the intensive care unit.

    Singer, P., Blaser, A. R., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., Hiesmayr, M., Mayer, K., Montejo, J. C., Pichard, C., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.037 · Cited by 2,904

    “Sarcopenia is defined as a decrease in muscle loss and/or function and is frequent in undernourished patients admitted to the ICU [27].”
  • GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community

    Cederholm, T., Jensen, G. L., Correia, M. I. T. D., Gonzalez, M. C., Fukushima, R., Higashiguchi, T., Baptista, G., Barazzoni, R., Blaauw, R., Coats, A. J. S., et al. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12383 · Cited by 1,724

    “Assessment of muscle strength should be an integral measure in assessment of patients with suspected sarcopenia since impairment of muscle strength is now recognized as a key component for diagnosis of sarcopenia.(15,16) Though inflammatory mediators and other mechanisms besides malnutrition are at play, it is recomme…”
    Background

See all 2,545

Metadata

Authors
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., Kiel, D. P., Kritchevsky, S. B., Shardell, M. D., Dam, T.-T. L., & Vassileva, M. T.
Affiliations
  • University of Pittsburgh (US)
  • California Pacific Medical Center (US)
  • University of Maryland, Baltimore (US)
  • Beth Israel Deaconess Medical Center (US)
  • National Institutes of Health (US)
  • University of Central Florida (US)
  • Wake Forest University Health Sciences (US)
  • Columbia University (US)
  • Foundation for the National Institutes of Health (US)
Corresponding author
Studenski, Stephanie A.
Venue
The Journals of Gerontology: Series A
Published
2014-03-31
Volume
69
Issue
5
Pages
547-558
ISSN
  • 1079-5006 (ISSN-L)
  • 1758-535X
OpenAlex
W2156791190
Cited by
2,545
References
41
Citations by year
2026: 186 · 2025: 315 · 2024: 270 · 2023: 254 · 2022: 257 · 2021: 272 · 2020: 246 · 2019: 206 · 2018: 195 · 2017: 138 · 2016: 86 · 2015: 85 · 2014: 29
FWCI
74.91
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • The Journals of Gerontology Series A (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • Journal of International Crisis and Risk Communication Research (submittedVersion)
Funders
  • Foundation for the National Institutes of Health (N01‐HC 25195, N01-AG-12100, P30 AG024827)
  • Patrick and Catherine Weldon Donaghue Medical Research Foundation
  • Amgen
  • Eli Lilly and Company
  • Ministero della Salute (263 MD 9164 13, N01-AG-916413, 263 MD 821336, N01-AG-821336, 263 MD 9164)
  • Syddansk Universitet
  • Hjartavernd (N01-AG-1-2100)
  • National Institutes of Health (N01-AG-6-2103, n01ag12100-57-0-2, N01-AG-916413, N01‐AG‐6‐2106, 263MD9164, 1u13ag041583-01, N01-AG-6-2101, n01hc25195-41-0-1, 263 MD 821336, N01-AG-821336, AR/AG41398)
  • University of California, San Diego
  • National Institute on Aging (N01‐AG‐6–2101, 263 MD 9164, R37AG007181, R01AG005394, N01AG-821336, DK31801, 263-MD-9164-13, 5P60AG13631, AG005407, 821336, 1U13AG041583, N01[AG]916413, N01-AG12100, N01-AG012100, AG027576, R01AR/AG 41398, AR/AG 41398, U01 AR45580, 263MD821336, U01-AG-18197, AG07181, N01-HC-25195, AG 024827, AG-6-2106, AG-6-2103, R01‐AR‐35584, R01AG018887, AG005394, U01AG018197, R01AG005407, R01 AR35583, U01 AR45632, U01AG027810, R01AG027576, P01AG023394, 916413, U01 AR45654, AG18197, R01AG007181, R01AG027087, U01 AR45614, AG-6-2101, AG028507, R01 AG18887, R01‐AR‐35582, U13 AG041583, N01AG62106, AG027574, U01 AR45583, AG027810, R01AG028507, U01 AR45647, AG41398, N01-AG-62103, R01AG027574, P30AG024827)
  • National Heart, Lung, and Blood Institute (N01-HC-025195, P50HL105185)
  • National Institute of Diabetes and Digestive and Kidney Diseases (N01-HC-25195, R01DK031801, DK-31801, AG07181)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (U01AR45614, R01 AR/AG 41398, R01-AR35582, U01-AR45632, N01-AG-12100, U01 AR45647, U01AR045583, R01AR035584, R01AR35583, U01 AR-45583, AR45654, AR45614, U01-AR-45654, AR45647, AR35583, U01AR045580, AR-35584, AR 35582, AR45583, U01AR045632, U01AR045654, R01AR035582, U01AR045614, AR45580, AR/AG 41398, U01AR045647, R01AR035583, U01 AG18197, AR45632, R01‐AR‐35584, U01AR45580)
  • National Center for Research Resources (U01 AR45654, RR-06192, U01 AR45632, M01RR006192, MO1 RR06192, U01 AR45580, U01 AR45647, UL1RR024140, U01 AR45614, U01 AR45583, U01 AG18197, RR024140)
  • National Institute on Minority Health and Health Disparities (R01MD009164)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
Keywords
sarcopenia, older adults, muscle weakness, appendicular lean mass, grip strength, body mass index, diagnostic criteria, cut-off values, community-dwelling older adults, biomarkers
MeSH terms
Age Factors, Aged, Aged, 80 and over, Disease Susceptibility, Female, Humans, Male, National Institutes of Health (U.S.), Research Design, Risk Factors, Sex Factors, United States, Body Mass Index, Hand Strength, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates. https://app.cochat.ai/papers/10.1093/gerona/glu010
The paper
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., Kiel, D. P., Kritchevsky, S. B., Shardell, M. D., Dam, T.-T. L., & Vassileva, M. T. (2014). The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates. The Journals of Gerontology: Series A. https://doi.org/10.1093/gerona/glu010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.